ReviewDrug design, development and therapy2017

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.

Corrado Pelaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.